Keith Bowering

Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial

S. Matthäei, Keith Bowering, Katja Rohwedder et al. · Diabetes Care · 2015 · 147 citations

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial

Keith Bowering, Christopher Case, John N. Harvey et al. · Diabetes Care · 2017 · 119 citations

Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes

S. Matthäei, Keith Bowering, Katja Rohwedder et al. · Diabetes Obesity and Metabolism · 2015 · 69 citations

Foot Care

John M. Embil, Zaina Albalawi, Keith Bowering et al. · Canadian Journal of Diabetes · 2018 · 40 citations

A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti‐hyperglycaemic medication: results of the PARADIGM study

Keith Bowering, Victoria Reed, João Felício et al. · Diabetic Medicine · 2012 · 39 citations